bpc 157 side effects human research Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing BPC-157 for athletes and injury
Description
However, 1-2% report symptoms consistent with low blood pressure, primarily dizziness upon standing, more commonly during the first 1-2 weeks as their body adjusts

They can prescribe FDA-approved drugs off-label, meaning for conditions other than their officially approved uses

Membranes were probed overnight at 4 C with primary antibodies against p-c-Met (3077 T, Cell signaling), c-Met (8198 S, Cell signaling), p-AKT (AF0016, affinity), AKT (GR100134-1, abcam), p-ERK (AF1015, affinity), ERK (4695 T, Cell signaling), GAPDH (10494-1-AP, proteintech), p-TRKB (4603 T, Cell signaling), CyclinD1 (26939-1-AP, proteintech), cleaved caspase-3 (9661 L, Cell signaling), caspase-3 (66470-2-Ig, proteintech), N-cadherin (22018-1-ap, proteintech), E-cadherin (AF0138, Beyotime), -actin (A5441, Sigma), AXL (4977, CST), p-MER (AF8443, affinity), P-AXL (334580, abmart), NF-KB (10745-1-AP, proteintech), p-ALK (3341 S, CST), Ki67 (27309-1-AP, proteintech)

Patients receiving anti-coagulation treatment, for whom intramuscular treatment may be contraindicated, should also benefit
This is because hydroxocobalamin stays in the body for longer

People taking certain medications are also at higher risk
